Patent Yard Sign in
Expired Canadian patentCanada

Medicinal emulsions

CA 2013755 C · Owner: Levy, Menashe · Inventors: Levy, Menashe; Benita, Simon

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A pharmaceutical composition being an oil in water type emulsion which comprises an effective amount of a lypophilic drug is provided. The composition comprises a synergistic combination consisting of about 3-50% of an oily carrier consisting of MCT oil optionally in combination with vegetable oil, about 0.05%-20% of a phospholipid about, 0.03-10% of a non-ionic surfactant and about 0.05-5% of an, ionic surfactant selected from the group consisting of bileduct surface active agent, cholic acid and their derivatives. Also provided is a novel method for preparing said composition.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 3, 1990 and granted November 30, 1993. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 3, 2010.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 3, 2012.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 3, 1990
GrantedNovember 30, 1993
Term endedApril 3, 2010
Patent numberCA 2013755 C
Classification (IPC)A61K9/12 +2 more

Timeline

Timeline From CIPO dates

1991199319951997199920012003200520072009Application filedApril 3, 1990Patent grantedNov 30, 1993Term endedApril 3, 2010

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.